Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.28−0.16 (-6.45%)
Close on Nov 20, 2026Market cap $4.07MP/E –Yield –
Scienture gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Scienture's gross profit for the twelve months ending Sep 30, 2026 was $1.17M, up 101.6% year over year. For fiscal 2025 it was $331.48K, up 5420.1% from the year before. Over ten years it grew -19.0% a year on average. The highest annual figure on record is $5.71M in fiscal 2020.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $331.48K | +5420.1% |
| FY2024 | Dec 31, 2024 | $6.01K | -87.8% |
| FY2023 | Dec 31, 2023 | $49.03K | -99.1% |
| FY2022 | Dec 31, 2022 | $5.52M | +16.3% |
| FY2021 | Dec 31, 2021 | $4.75M | -16.8% |
| FY2020 | Dec 31, 2020 | $5.71M | +17.2% |
| FY2019 | Dec 31, 2019 | $4.87M | +44.0% |
| FY2018 | Dec 31, 2018 | $3.38M | +15.4% |
| FY2017 | Dec 31, 2017 | $2.93M | +18.1% |
| FY2016 | Dec 31, 2016 | $2.48M | -8.8% |
| FY2015 | Dec 31, 2015 | $2.72M | +157.8% |
| FY2014 | Dec 31, 2014 | $1.06M | +8842.3% |
| FY2013 | Dec 31, 2013 | $11.81K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.02M | +77.5% |
| Q2 FY2026 | Jun 30, 2026 | $335.78K | – |
| Q1 FY2026 | Mar 31, 2026 | $53.85K | +7901.5% |
| Q4 FY2025 | Dec 31, 2025 | -$243.81K | -8730.5% |
| Q3 FY2025 | Sep 30, 2025 | $574.62K | +14698.4% |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $673 | – |
| Q4 FY2024 | Dec 31, 2024 | $2.83K | -92.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.88K | -94.2% |
| Q2 FY2024 | Jun 30, 2024 | -$703 | -101.0% |
| Q4 FY2023 | Dec 31, 2023 | -$113.96K | -107.5% |
| Q3 FY2023 | Sep 30, 2023 | $39.59K | -97.1% |
| Q2 FY2023 | Jun 30, 2023 | $67.14K | -94.3% |
| Q1 FY2023 | Mar 31, 2023 | $73.22K | -94.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.52M | +22.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.37M | +7.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.17M | +39.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.34M | -3.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.24M | +831.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.28M | -33.6% |
| Q2 FY2021 | Jun 30, 2021 | $841.39K | -58.0% |
| Q1 FY2021 | Mar 31, 2021 | $1.38M | -15.7% |
| Q4 FY2020 | Dec 31, 2020 | $133.11K | -89.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.93M | +47.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.00M | +72.3% |
| Q1 FY2020 | Mar 31, 2020 | $1.64M | +43.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.25M | +47.6% |
| Q3 FY2019 | Sep 30, 2019 | $1.31M | +55.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.16M | +38.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.15M | +34.4% |
| Q4 FY2018 | Dec 31, 2018 | $846.99K | +7.2% |
| Q3 FY2018 | Sep 30, 2018 | $845.13K | +14.8% |
| Q2 FY2018 | Jun 30, 2018 | $837.69K | +18.9% |
| Q1 FY2018 | Mar 31, 2018 | $852.92K | +14.3% |
| Q4 FY2017 | Dec 31, 2017 | $789.74K | +20.7% |
| Q3 FY2017 | Sep 30, 2017 | $735.87K | – |
| Q2 FY2017 | Jun 30, 2017 | $704.73K | – |
| Q1 FY2017 | Mar 31, 2017 | $745.94K | – |
| Q4 FY2016 | Dec 31, 2016 | $654.39K | – |
See a number that looks wrong?